Further, we associated the SRS with the tumor microenvironment and drug sensitivity, identifying and validating the oncogenic role of key gene TOMM40L, providing new perspectives for HCC diagnosis, treatment, and prognosis. This evidence concerns the gene TOMM40L and neoplasm.